|
74
|
275
|
7p3vA |
B-raf v600e structure bound to a new inhibitor |
|
236
|
948
|
6xrnA |
Crystal structure of human pi3k-gamma in complex with compound 17 |
|
310
|
946
|
7jiuA |
Human pi3kdelta in complex with compound 2f |
|
49
|
134
|
7p4sA |
Bromodomain of human taf1 (2) with naphthyridinone compound |
|
18
|
97
|
7okwA |
1.62a x-ray crystal structure of the conserved c-terminal (cct) of human osr1 |
|
22
|
96
|
7o86A |
1.73a x-ray crystal structure of the conserved c-terminal (cct) of human spak |
|
83
|
273
|
7oowA |
Crystal structure of pim1 in complex with arc-1415 |
|
85
|
273
|
7oovA |
Crystal structure of pim1 in complex with arc-1411 |
|
30
|
125
|
7o3bG |
Crystal structure of the ttbk2-cep164 complex bound to a camelid nanobody |
|
513
|
1541
|
7ni6A |
Human atm kinase with bound atpys |
|
117
|
442
|
7nh5A |
Co-crystal structure of akt1 in complex with covalent-allosteric akt inhibitor 6 |
|
114
|
441
|
7nh4A |
Co-crystal structure of akt1 in complex with covalent-allosteric akt inhibitor 3 |
|
67
|
276
|
7naaA |
Crystal structure of mycobacterium tuberculosis h37rv pknf kinase domain |
|
290
|
1052
|
7mezA |
Structure of the phosphoinositide 3-kinase p110 gamma (pik3cg) p101 (pik3r5) complex |
|
75
|
295
|
7lvhA |
Crystal structure of ap2 associated kinase 1 isoform 1 complexed with ligand n-[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]-3-(propan-2-yl)piperidine-2-carboxamide |
|
83
|
297
|
7lviA |
Crystal structure of ap2 associated kinase 1 isoform 1 complexed with ligand (2r)-2-amino-n-[3-methoxy-4- (1,3-oxazol-5-yl)phenyl]-4-methylpentanamide |
|
79
|
268
|
7kx6A |
Crystal structure of dclk1-kd in complex with xmd8-85 |
|
101
|
328
|
7l1xA |
Structure of human ck2 alpha kinase (catalytic subunit) with the inhibitor 108600. |
|
69
|
267
|
7kxwA |
Crystal structure of dclk1-kd in complex with dclk1-in-1 |
|
73
|
268
|
7kxwB |
Crystal structure of dclk1-kd in complex with dclk1-in-1 |
|
64
|
288
|
7kx8A |
Crystal structure of dclk1-cter in complex with fmf-03-055-1 |
|
99
|
252
|
7k6fA |
Crystal structure of the tandem bromodomain (bd1, bd2) of human taf1 in complex with mes (2-(n-morpholino)ethanesulfonic acid) |
|
48
|
123
|
7k42A |
Crystal structure of the second bromodomain (bd2) of human taf1 bound to dioxane |
|
49
|
123
|
7k3oA |
Crystal structure of the unliganded second bromodomain (bd2) of human taf1 |
|
7
|
23
|
7lwhB |
Human neurofibromin 2/merlin residues 1-339 in complex with lats1 |
|
101
|
250
|
7k0dA |
Crystal structure of the tandem bromodomain (bd1, bd2) of human taf1 bound to mtorc1/2 inhibitor azd3147 |
|
102
|
248
|
7k03A |
Crystal structure of the tandem bromodomain (bd1 and bd2) of human taf1 bound to atr kinase inhibitor azd6738 |
|
52
|
130
|
7k1pA |
Crystal structure of the second bromodomain (bd2) of human taf1 bound to bromosporine |
|
55
|
137
|
7jjgA |
Crystal structure of the second bromodomain (bd2) of human taf1 bound to atr kinase inhibitor az20 |
|
54
|
128
|
7k0uA |
Crystal structure of the second bromodomain (bd2) of human taf1 bound to plk1 kinase inhibitor bi2536 |
|
98
|
247
|
7k27A |
Crystal structure of the tandem bromodomain (bd1, bd2) of human taf1 bound to atr inhibitor az20 |
|
58
|
135
|
7jtcA |
Crystal structure of the second bromodomain (bd2) of human taf1 bound to zs1-322 |
|
55
|
137
|
7jspA |
Crystal structure of the second bromodomain (bd2) of human taf1 bound to atr kinase inhibitor azd6738 |
|
72
|
273
|
7f3gA |
Crystal structure of dclk1 kinase domain in complex with ruxolitinib |
|
504
|
1544
|
7ni4A |
Human atm kinase domain with bound m4076 inhibitor |
|
72
|
290
|
7cp3A |
Crystal structure of pak4 in complex with inhibitor 47 |
|
91
|
292
|
7cp4A |
Crystal structure of pak4 in complex with inhibitor 55 |
|
140
|
406
|
7bmkA |
Atp-competitive partial antagonists-'pair's-rheostatically modulate ire1alpha's kinase helix-alphac to segregate its rnase-mediated biological outputs |
|
113
|
328
|
7atvA |
Structure of protein kinase ck2 catalytic subunit (csnk2a2 gene product) in complex with the bivalent inhibitor kn2 |
|
108
|
430
|
7apjA |
Structure of autoinhibited akt1 reveals mechanism of pip3-mediated activation |
|
111
|
328
|
7at9A |
Structure of protein kinase ck2 catalytic subunit (csnk2a2 gene product) in complex with the atp-competitive inhibitor mb002 and the alphad-pocket ligand 3,4-dichlorophenethylamine |
|
117
|
332
|
7at5A |
Structure of protein kinase ck2 catalytic subunit (csnk2a1 gene product) in complex with the bivalent inhibitor kn2 |
|
53
|
299
|
7a0jAAA |
Crystal structure of the crinkly wd40 ectodomain from the arabidopsis thaliana receptor kinase acr4 |
|
65
|
355
|
6zueB |
Crystal structure of human ddb1 bound to human dcaf1 (amino acid residues 1046-1396) |
|
171
|
482
|
7s67A |
Extended conformation of daytime state kaic |
|
167
|
485
|
7s66A |
Extended conformation of nighttime state kaic |
|
160
|
460
|
7s65A |
Compressed conformation of nighttime state kaic |
|
606
|
2555
|
7pe8A |
Cryo-em structure of deptor bound to human mtor complex 2, focussed on one protomer |
|
615
|
2555
|
7pe9A |
Cryo-em structure of deptor bound to human mtor complex 2, dept-bound subset local refinement |
|
615
|
2555
|
7pe7A |
Cryo-em structure of deptor bound to human mtor complex 2, overall refinement |
